CD59 and esophageal squamous cell carcinoma: To identify the relationship between CD59 expression and radiosensitivity in ESCC patients, we collected 24 ESCC clinical specimens before radiotherapy, of which half were classified as radiosensitive and half as radioresistant based on their recurrence after radiotherapy.